4-[(4-Chlorophenyl)amino]-4-oxobutanoic acid

CAS : 17722-52-0

Ref. 3D-FC126496

Informations sur le produit

• Nom: 4-[(4-Chlorophenyl)amino]-4-oxobutanoic acid
• Synonymes: butanoic acid, 4-[(4-chlorophenyl)amino]-4-oxo-, Butanoic Acid, 4-[(4-Chlorophenyl)Amino]-4-Oxo-

Description

4-[(4-Chlorophenyl)amino]-4-oxobutanoic acid is a hydroxylated metabolite of ocrelizumab, a humanized monoclonal antibody that targets CD20. 4-[(4-Chlorophenyl)amino]-4-oxobutanoic acid inhibits the proliferation of lymphocytes and macrophages, which is caused by its ability to inhibit the production of proinflammatory cytokines. This drug has been shown to be effective for the treatment of autoimmune diseases such as multiple sclerosis, rheumatoid arthritis, and Crohn’s disease. It also has beneficial effects on body mass index and disease activity in patients with these diseases.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 227.64 g/mol
• Formule: C₁₀H₁₀ClNO₃
• Degré de pureté: Min. 95%
• InChI: InChI=1S/C10H10ClNO3/c11-7-1-3-8(4-2-7)12-9(13)5-6-10(14)15/h1-4H,5-6H2,(H,12,13)(H,14,15)
• Code InChI: InChIKey=UPSNSRKMOHOEEO-UHFFFAOYSA-N
• SMILES: O=C(O)CCC(=O)Nc1ccc(Cl)cc1